- Jefferies has issued a "Buy" rating for Raia Drogasil (OTCQX: RADLY), a prominent Brazilian pharmacy retailer, despite recent share price drops.
- The company's latest quarterly earnings per share of $0.05 met analyst expectations, though its revenue of $2.17 billion fell short of forecasts.
- Raia Drogasil maintains a market capitalization of approximately $6.64 billion, with its shares recently trading between $3.80 and $3.81.
RADLY is the U.S.-traded share of Raia Drogasil, a Brazilian pharmacy retailer. Jefferies upgrades the stock to Buy while it trades at $3.80. A Buy rating means the firm expects the shares to perform well, but it does not guarantee a gain.
The upgrade comes as RADLY trades lower. As highlighted by Defense World, the shares open at $3.81 on Friday after a previous close of $4.01, then last trade at $3.80. That is a drop of about 5.2% from the stated close. The article also reports a 9.1% decline, which does not match those prices.
Raia Drogasil earns $0.05 per share in its latest reported quarter, matching analysts’ estimates. Revenue reaches $2.17 billion, below the $2.32 billion analysts expect. Revenue is the money the company brings in from sales before expenses, so the shortfall shows that sales miss forecasts even though earnings per share meet them.
RADLY trades between $3.80 and $3.81 during the session, compared with a range of $3.10 to $5.34 over the past year. Its market capitalization is approximately $6.64 billion. Defense World reports volume of 747 shares, a small number of shares changing hands that day.
